Health care leaders' letter to the FDA: Concerns about approvals for rare disease therapeutics

All right, welcome back everybody. CNBC has learned that healthcare industry leaders have sent a letter to President Trump to the Health and Human Services Secretary Robert F. Kennedy Jr.. and the head of the FD FDA, Dr. . Marty McCary. The leaders who are speaking up here are lod lodging some frustration with the FDA when it comes to approvals of potentially life-saving therapeutics for rare diseases.The group of U letter signitories are made up of biotech leaders, patient advocates, and academics who work ...